信级医药 is a pharmaceutical R&D services provider that integrates cell drug R&D, clinical trials, hospital patient recruitment, and clinical management. The company has established eight industry clusters covering biopharma, cell therapy, gene engineering, patient recruitment, medical services, drug metabolism, and other areas. To accelerate cell drug development and clinical trial stages, it has created a patient recruitment "green channel" through hospital partnerships to optimize processes and shorten approval times. The green channel is intended to provide more convenient recruitment for patients participating in clinical trials. Recently, the company raised $35 million in a Pre-A round. Goldman Sachs (China) Investment is listed as the investor in that financing.

Total raised

$35M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2024